Search

Your search keyword '"Tolosa, C."' showing total 284 results

Search Constraints

Start Over You searched for: Author "Tolosa, C." Remove constraint Author: "Tolosa, C."
284 results on '"Tolosa, C."'

Search Results

1. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

2. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

3. Timing and characteristics of venous thromboembolism after noncancer surgery

4. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

5. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

6. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

7. Systemic phenotype of sarcoidosis associated with radiological stages. Analysis of 1230 patients

8. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

9. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

10. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

11. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

12. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

13. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

14. First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study

15. DVT Management and Outcome Trends, 2001 to 2014

16. A prognostic score to identify low‐risk outpatients with acute deep vein thrombosis in the upper extremity

17. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism

18. Surgical results of type I tympanoplasty during the years 2014 to 2019, at the hospital universitario clínica San Rafael in Bogotá

19. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

20. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

21. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

22. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: 'AbSeS', a multinational observational cohort study and ESICM Trials Group Project

23. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

24. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

26. P59.31 A High Number of Co-Current Genetic Alterations Is Associated With Poor Survival in EGFR Mutated Metastatic NSCLC Patients

27. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

28. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

29. Timing and characteristics of venous thromboembolism after noncancer surgery

31. The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis

32. Predictors of active cancer thromboembolic outcomes

33. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

35. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

36. Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry

37. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism

38. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

39. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with Systemic Sclerosis in a large European cohort

40. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

44. FRI0242 IMPACT OF PULMONARY ARTERIAL HYPERTENSION WITH OR WITHOUT INTERSTITIAL LUNG DISEASE ON SCLERODERMA: A RETROSPECTIVE COHORT STUDY FROM THE NATIONWIDE SPANISH SCLERODERMA (RESCLE) AND PULMONARY ARTERIAL HYPERTENSION (REHAP) REGISTRIES

45. SAT0316 ANTI-PM/SCL ANTIBODIES IN SYSTEMIC SCLEROSIS: CLINICAL ASSOCIATIONS IN THE RESCLE COHORT

46. THU0361 EPIDEMIOLOGIC VARIATION ON SCLERODERMA RENAL CRISIS AND CLINICAL FEATURES VARIATION ON SYSTEMIC SCLEROSIS PATIENTS OVER TIME: DATA FROM RESCLE REGISTRY.

47. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

49. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry

50. Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry

Catalog

Books, media, physical & digital resources